Publications

46 Peer-Reviewed Articles

18 First / Last Author

18 H-Index (Google Scholar)

1,112 Citations

Google Scholar PubMed Search ORCID: 0000-0001-9729-9974

Publication list as of 29 October 2026. Citation metrics from Google Scholar (h-index 18, i10-index 27). One further case report in Ugeskrift for Læger (2017) is listed under section IV.

Selected publications

Five papers that show what I work on. The full list follows below.

  • Eadon MT, Hein DW, Andersen MA, Chapman AB, Cooper-DeHoff RM, Desta Z, …, Agúndez JAG. Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy. Clin Pharmacol Ther 2025;118(6):1430-1436. [PubMed]
  • Andersen MA, Helms Andreasen A, Evi Bang L, Jimenez-Solem E, Petersen TS. A register-based cohort study on the effectiveness and Safety of anti-PCSK9 treatment in persons with hyperlipidemia. Commun Med (Lond) 2024;4(1):193. [PubMed]
  • Damkier P, Andersen MA. Temporary Like Achilles: Pre-emptive germline pharmacogenetic testing. Basic Clin Pharmacol Toxicol 2023;133(4):397-399. [PubMed]
  • Agius R, Brieghel C, Andersen MA, Pearson AT, Ledergerber B, Cozzi-Lepri A, …, Niemann CU. Machine learning can identify newly diagnosed patients with CLL at high risk of infection. Nat Commun 2020;11(1):363. [PubMed]
  • Andersen MA, Moser CE, Lundgren J, Niemann CU. Epidemiology of bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal nation-wide cohort study. Leukemia 2019;33(3):662-670. [PubMed]

I. Original scientific publications (peer reviewed)

  1. Andersen MA, Vojdeman FJ, Andersen MK, Brown Pde N, Geisler CH, Weis Bjerrum O, Niemann CU. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia is a predictor of early death. Leuk Lymphoma 2016;57(7):1592-9. [PubMed]

  2. Johansen MM, Andersen MA, Grønbaek K, Hansen JW. Long-term clinical outcomes of patients with hematologically unexplained cytopenia after routine assessment: A single center study. Eur J Haematol 2018;101(5):595-603. [PubMed]

  3. Andersen MA, Bjerrum OW, Ranjan A, Skov V, Kruse TA, Thomassen M, …, Christensen K. Myeloproliferative Neoplasms in Danish Twins. Acta Haematol 2018;139(3):195-198. [PubMed]

  4. Brieghel C, Kinalis S, Yde CW, Schmidt AY, Jønson L, Andersen MA, …, Niemann CU. Deep targeted sequencing of TP53 in chronic lymphocytic leukemia: clinical impact in the era of targeted therapy. Haematologica 2019;104(4):789-796. [PubMed]

  5. Andersen MA, Moser CE, Lundgren J, Niemann CU. Epidemiology of bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal nation-wide cohort study. Leukemia 2019;33(3):662-670. (Erratum: Leukemia 2020;34(10):2817-2818). [PubMed]

  6. Hleuhel MH, Ben-Dali Y, Da Cunha-Bang C, Brieghel C, Clasen-Linde E, Niemann CU, Andersen MA. Risk factors associated with Richter’s transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study. BMJ Open 2019;9(3):e023566. [PubMed]

  7. Agius R, Brieghel C, Andersen MA, Pearson AT, Ledergerber B, Cozzi-Lepri A, …, Niemann CU. Machine learning can identify newly diagnosed patients with CLL at high risk of infection. Nat Commun 2020;11(1):363. [PubMed]

  8. Aarup K, Rotbain EC, Enggaard L, Pedersen RS, Bergmann OJ, Thomsen RH, …, Niemann CU. Real-world outcomes for 205 patients with chronic lymphocytic leukemia treated with ibrutinib. Eur J Haematol 2020;105(5):646-654. [PubMed]

  9. Ben-Dali Y, Hleuhel MH, da Cunha-Bang C, Brieghel C, Poulsen CB, Clasen-Linde E, …, Andersen MA. Richter’s transformation in patients with chronic lymphocytic leukaemia: a Nationwide Epidemiological Study. Leuk Lymphoma 2020;61(6):1435-1444. [PubMed]

  10. Brieghel C, da Cunha-Bang C, Yde CW, Schmidt AY, Kinalis S, Nadeu F, …, Niemann CU. The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome. Clin Cancer Res 2020;26(6):1507-1515. [PubMed]

  11. Andersen MA, Rostgaard K, Niemann CU, Hjalgrim H. Antimicrobial use before chronic lymphocytic leukemia: a retrospective cohort study. Leukemia 2021;35(3):747-751. [PubMed]

  12. Brieghel C, Aarup K, Torp MH, Andersen MA, Yde CW, Tian X, …, Niemann CU. Clinical and Biological Implications of Multi-Hit Versus Single-Hit TP53 Inactivation in Chronic Lymphocytic Leukemia. Clin Cancer Res 2021;27(16):4531-4538. [PubMed]

  13. Andersen MA, Niemann CU, Rostgaard K, Dalby T, Sørrig R, Weinberger DM, Hjalgrim H, Harboe ZB. Differences and Temporal Changes in Risk of Invasive Pneumococcal Disease in Adults with Hematological Malignancies: Results from a Nationwide 16-Year Cohort Study. Clin Infect Dis 2021;72(3):463-471. [PubMed]

  14. Rotbain EC, Rostgaard K, Andersen MA, Da Cunha-Bang C, Niemann CU, Frederiksen H, Hjalgrim H. Healthcare Utilization and Comorbidity in Chronic Lymphocytic Leukemia. Clin Epidemiol 2021;13:1155-1165. [PubMed]

  15. da Cunha-Bang C, Rostgaard K, Andersen MA, Rotbain EC, Grønbaek K, Frederiksen H, Niemann CU, Hjalgrim H. Risk of new malignancies among patients with CLL treated with chemotherapy: results of a Danish population-based study. Br J Haematol 2021;193(2):339-345. [PubMed]

  16. Davidsson OB, Olofsson IA, Kogelman LJ, Andersen MA, Rostgaard K, Hjalgrim H, Olesen J, Hansen TF. Twenty-five years of triptans - a nationwide population study. Cephalalgia 2021;41(8):894-904. [PubMed]

  17. Svanberg R, MacPherson C, Zucco A, Agius R, Faitova T, Andersen MA, …, Ostrowski SR. Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients. Commun Med (Lond) 2022;2:114. (Author Correction: Commun Med 2023;3:15). [PubMed]

  18. Staerk-Østergaard J, Kirkeby C, Christiansen LE, Andersen MA, Møller CH, Voldstedlund M, Denwood MJ. Evaluation of diagnostic test procedures for SARS-CoV-2 using latent class models. J Med Virol 2022;94(10):4754-4761. [PubMed]

  19. Brieghel C, Galle V, Agius R, da Cunha-Bang C, Andersen MA, Vlummens P, …, Niemann CU. Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?. Eur J Haematol 2022;108(5):369-378. [PubMed]

  20. Andersen MA, Grand MK, Brieghel C, Siersma V, Andersen CL, Niemann CU. Pre-diagnostic trajectories of lymphocytosis predict time to treatment and death in patients with chronic lymphocytic leukemia. Commun Med (Lond) 2022;2:50. [PubMed]

  21. Nielsen KF, Moustsen-Helms IR, Schelde AB, Gram MA, Emborg HD, Nielsen J, …, Valentiner-Branth P. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study. PLoS Med 2022;19(11):e1004037. [PubMed]

  22. Rotbain EC, Allmer C, Rostgaard K, Andersen MA, Vainer N, da Cunha-Bang C, …, Niemann CU. Impact of type 2 diabetes on mortality, cause of death, and treatment in chronic lymphocytic leukemia. Am J Hematol 2023;98(8):1236-1245. [PubMed]

  23. Roen A, Terrones C, Bannister W, Helleberg M, Andersen MA, Niemann CU, …, Lundgren J. Increased incidence rates of positive blood cultures shortly after chemotherapy compared to radiotherapy among individuals treated for solid malignant tumours. Infection 2023;51(1):147-157. [PubMed]

  24. Vainer N, Aarup K, Andersen MA, Wind-Hansen L, Nielsen T, Frederiksen H, …, Rotbain EC. Real-world outcomes upon second-line treatment in patients with chronic lymphocytic leukaemia. Br J Haematol 2023;201(5):874-886. [PubMed]

  25. Andersen MA, Helms Andreasen A, Evi Bang L, Jimenez-Solem E, Petersen TS. A register-based cohort study on the effectiveness and Safety of anti-PCSK9 treatment in persons with hyperlipidemia. Commun Med (Lond) 2024;4(1):193. [PubMed]

  26. Andersen MA, Gregersen R, Petersen TS, Wang JN, Petersen J, Jimenez-Solem E. Association Between First-time Neurologic Events and Metronidazole Treatment: A Case-time Control Study. Clin Ther 2024;46(4):307-312. [PubMed]

  27. Andersen MA, Jensen TL, Petersen TS. Data Resource Profile: The Danish National Hospital Medicine Register. Pharmacoepidemiol Drug Saf 2024;33(11):e70054. [PubMed]

  28. Packness E, Davidsson OB, Rostgaard K, Andersen MA, Rotbain EC, Niemann CU, Brieghel C, Hjalgrim H. Infections and their prognostic significance before diagnosis of chronic lymphocytic leukemia, non-Hodgkin lymphoma, or multiple myeloma. Br J Cancer 2024;131(7):1186-1194. [PubMed]

  29. Windfeld-Mathiasen J, Heerfordt IM, Dalhoff KP, Andersen JT, Andersen MA, Johansson KS, …, Horwitz H. Cardiovascular Disease in Anabolic Androgenic Steroid Users. Circulation 2025;151(12):828-834. [PubMed]

  30. Brieghel C, Lacoppidan T, Packness E, Frederiksen CM, Werling M, Andersen MA, …, Niemann CU. Polypharmacy independently predicts survival, hospitalization, and infections in patients with lymphoid cancer. Hemasphere 2025;9(7):e70172. [PubMed]

  31. Christensen LWS, Boas AK, Clausen E, Koch NE, Walls AB, Nørgaard LS, …, Houlind MB. Clinical relevance of pharmacogenomic information for improving prescribing practices in acutely admitted older medical patients. Br J Clin Pharmacol 2026;10.1002/bcp.70799. [PubMed]

II. Clinical guidelines and consortia (peer reviewed)

  1. Eadon MT, Hein DW, Andersen MA, Chapman AB, Cooper-DeHoff RM, Desta Z, …, Agúndez JAG. Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy. Clin Pharmacol Ther 2025;118(6):1430-1436. [PubMed]

III. Scientific reviews (peer reviewed)

  1. Del Giudice I, Cappelli LV, Delgado J, Niemann CU, Andersen MA, Rotbain EHC, …, Foà R. Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature. Br J Haematol 2023;201(2):353-356. [PubMed]

  2. Karlsen APH, Sunde PB, Olsen MH, Laigaard J, Folkersen C, Tran TXM, …, Mathiesen O. Opioids and personalized analgesia in the perioperative setting: A protocol for five systematic reviews. Acta Anaesthesiol Scand 2024;68(10):1573-1580. [PubMed]

  3. Erichsen PA, Dalhoff K, Andersen MA. Should high-dose N-acetylcysteine be given in cases of massive paracetamol overdoses: A narrative review. Basic Clin Pharmacol Toxicol 2024;135(3):285-294. [PubMed]

  4. Korsholm C, Bülow C, Christensen M, Dalhoff K, Feinberg JB, Lund TM, …, Andersen MA. Drug exposure and measurable residual disease in chronic lymphocytic leukemia: a systematic review. Leuk Lymphoma 2025;66(2):229-239. [PubMed]

  5. Breining P, Bork CS, Bartels LE, Andersen MA. Statin-induced muscle symptoms. Ugeskr Laeger 2025;187(43):V03250169. [PubMed]

  6. Kjartansdóttir SP, Folkersen C, Rasmussen IH, Sunde PB, Saito A, Maagaard M, …, Karlsen APH. Pharmacogenetic Predictors of Postoperative Opioid-Related Adverse Events: A Systematic Review. Basic Clin Pharmacol Toxicol 2026;138(2):e70154. [PubMed]

  7. Bentsen MS, Bundgaard JS, Brøns N, Rand SA, Andersen MA, Rossing M, …, Ostrowski SR. Clinical pharmacogenetics and the use of biobanks. Ugeskr Laeger 2026;188(37):V01260062. [PubMed]

IV. Short reports, commentaries and other peer reviewed publications

  1. Andersen MA, Nielsen RT. Spontaneous renal rupture of fornix due to obstructing urethral stone. Ugeskr Laeger 2017;179(36):V02170114. [PubMed]

  2. Andersen MA, Niemann CU. Immune failure, infection and survival in chronic lymphocytic leukemia in Denmark. Haematologica 2018;103(7):e330. [PubMed]

  3. Andersen MA, Eriksen CT, Brieghel C, Biccler JL, Cunha-Bang CD, Helleberg M, Niemann CU. Incidence and predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study. Haematologica 2018;103(7):e300-e303. [PubMed]

  4. Andersen MA, Valentin R, Dissing Sjö L, Borgwardt L, Schmiegelow K, Andersen MK, …, Niemann CU. Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma. Acta Oncol 2020;59(12):1547-1551. [PubMed]

  5. Egholm GJ, Andersen MA, Andersen CL, Frederiksen H, Bjerrum OW, Niemann CU. Abnormal eosinophil count at CLL diagnosis correlates with shorter treatment free survival. Br J Haematol 2021;192(3):e81-e84. [PubMed]

  6. Vojdeman FJ, Helby J, Pedersen LB, Brieghel C, Andersen MA, Nordestgaard BG, Bojesen SE, Niemann CU. Chronic lymphocytic leukaemia clones are detectable decades before diagnosis. Br J Haematol 2022;196(3):784-787. [PubMed]

  7. Damkier P, Andersen MA. Temporary Like Achilles: Pre-emptive germline pharmacogenetic testing. Basic Clin Pharmacol Toxicol 2023;133(4):397-399. [PubMed]

  8. Windfeld-Mathiasen J, Heerfordt IM, Dalhoff KP, Andersen JT, Andersen MA, Johansson KS, …, Horwitz H. Response by Windfeld-Mathiasen et al to Letter Regarding Article, “Cardiovascular Disease in Anabolic Androgenic Steroid Users”. Circulation 2025;152(16):e296-e297. [PubMed]